Evolus, Inc. (EOLS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$5.28
+1.05%
Mkt Cap $344.82M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (8 analysts)
$15.00
Range $13.00 – $17.00
Implied Upside
+184.4%
Consensus $15.00 vs current $5.28